Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone-treated rats

Experimental Physiology

Volumn 88, Issue 2, 2003, Pages 243-250

  Wangensteen, Rosemary ^a   Sainz, Juan ^a   Rodríguez Gomez, Isabel ^a   Moreno, Juan Manuel ^a   Osuna, Antonio ^a   Vargas, Félix ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; DEOXYCORTICOSTERONE ACETATE; DRINKING WATER; NITRIC OXIDE SYNTHASE; RENIN; SODIUM; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; MORPHOLOGY; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; REVIEW; SODIUM INTAKE; SODIUM RETENTION; SYSTOLIC BLOOD PRESSURE; TAIL;

EID: 0037339223     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/eph8802489     Document Type: Review

References (36)

1. Abram SR, Alexander BT, Bennett WA & Granger JP (2001). Role of neuronal nitric oxide synthase in mediating renal hemodynamic changes during pregnancy. Am J Physiol Regul Integr Comp Physiol 281, R1390-1393.
2. Alvarez G, Osuna A, Wangensteen R & Vargas F (2000). Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure. Hypertension 35, 752-757.
3. Beierwaltes WH (1995). Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am J Physiol 269, F134-139.
4. Beierwaltes WH (1997). Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthase. Am J Physiol 272, R1359-1364.
5. De Gracia MC, Osuna A, O'Valle F, Del Moral RG, Wangensteen R, García Del Río C & Vargas F (2000). Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. J Am Soc Nephrol 11, 1995-2000.
6. Fujihara CK, Michellazzo SM, De-Nucci G & Zatz R (1994). Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 266, F697-705.
7. Gozal D, Torres JE, Gozal YM & Littwin SM (1996). Effect of nitric oxide synthase inhibition on cardiorespiratory responses in the conscious rat. J Appl Physiol 81, 2068-2077.
8. Haber ET, Koerner LB, Page B, Kilman B & Purnode A (1969). Application of radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29, 1349-1355.
9. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH & Carretero OA (1997). Cyclooxygenase-2 mediates increased renal renin content induced by low sodium diet. Hypertension 29, 297-302.
10. Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA & Fishman MC (1995). Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377, 239-242.
11. Komers R, Oyama TT, Chapman JG, Allison KM & Anderson S (2000). Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension 33, 655-661.
12. Kone B & Baylis C (1997). Biosynthesis and homeostatic role of nitric oxide in the normal kidney. Am J Physiol 272, F561-578.
13. Kurose T, Ueta Y, Nomura M, Yamaguchi K & Nagata S (2001). Nociceptive stimulation increases NO synthase mRNA and vasopressin heteronuclearRNA in the rat paraventricular nucleus. Auton Neurosci 88, 52-60.
14. Kurtz A & Wagner C (1998). Role of nitric oxide in the control of renin secretion. Am J Physiol 275, F849-862.
15. Lee S, Kim CK & Rivier C (1999). Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat. J Neurosci 19, 7640-7647.
16. Mattson DL & Bellehumeur TG (1996). Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension 28, 297-303.
17. Medhurst AD, Greenlees C, Parsons AA & Smith SJ (1994). Nitric oxide synthase inhibitors 7- and 6-nitroindazole relax smooth muscle in vitro. Eur J Pharmacol 256, R5-6.
18. Moore PK, Wallace P, Gaffen Z, Hart SL & Babbedge RC (1993). Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 110, 219-224.
19. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM & Snyder SH (1995). Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378, 383-386.
20. Nylen A, Skagerberg G, Alm P, Larsson B, Holmqvist B & Andersson KE (2001). Nitric oxide synthase in the hypothalamic paraventricular nucleus of the female rat; organization of spinal projections and coexistence with oxytocin or vasopressin. Brain Res 908, 10-24.
21. Ollerstam A, Pittner J, Persson AEG & Thorup C (1997). Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest 99, 2212-2218.
22. Ollerstam A, Skott O, Ek J, Persson AEG & Thorup C (2001). Effects of long-term inhibition of neuronal nitric oxide synthase on blood pressure and renin release. Acta Physiol Scand 173, 351-358.
23. Romero JC, Lahera V, Salom MG & Biondi ML (1992). Role of endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol 2, 1371-1387.
24. Salom MG, Lahera V, Miranda-Guardiola F & Romero JC (1992). Blockade of pressure-natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol 262, F718-722.
25. Schricker K & Kurtz A (1996). Blockade of nitric oxide formation inhibits the stimulation of the renin system by a low salt intake. Pflugers Arch 432, 187-191.
26. Schultz PJ & Tolins JP (1993). Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J Clin Invest 91, 642-650.
27. Selye H, Hall CE & Rowley EM (1943). Malignant hypertension produced by treatment with deoxicorticosterone acetate and sodium chloride. Can Med Assoc J 49, 88-92.
28. Sigmon DH & Beierwaltes WH (2000). Influence of nitric oxide derived from neuronal nitric oxide synthase in glomerular filtration. Gen Pharmacol 34, 95-100.
29. Singh IM, Grams M, Wang WH, Yang T, Killen P, Smart A, Schnermann J & Brigss JP (1996). Coordinated regulation of renal expression of nitric oxide synthase, renin and angiotensinogen mRNA by dietary salt. Am J Physiol 270, F1027-1037.
30. Tan DY, Meng S & Manning D (1999). Role of neuronal nitric oxide in Dahl salt-sensitive hypertension. Hypertension 33, 456-461.
31. Thorup C & Persson AEG (1994). Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol 267, F606-611.
32. Thorup C & Persson AEG (1998). Nitric oxide and renal blood pressure regulation. Curr Opin Nephrol Hypertens 7, 197-202.
33. - absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice. Am J Physiol Renal Physiol 279, F518-524.
34. Wang Q, Pelligrino DA, Baughman VL, Koenig HM & Albrecht RF (1995). The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb Blood Flow Metab 15, 774-778.
35. Xu L, Carter EP, Ohara M, Martin PY, Rogachev B, Morris K, Cadnapaphornchai M, Knotek M & Schrier RW (2000). Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J Physiol Renal Physiol 279, F1110-1115.
36. Zatz R & Baylis C (1998). Chronic nitric oxide inhibition model six years on. Hypertension 32, 958-964.